Da Hee Han

PharmD

Most Recent Articles by Da Hee Han

FDA Expands Pediatric Age Range for Contrast Agent

FDA Expands Pediatric Age Range for Contrast Agent

By

The FDA has approved an expanded age range for MultiHance contrast agent.

FDA Reviewing NDA for Hereditary aTTR Amyloidosis Gene-Silencing Therapy

FDA Reviewing NDA for Hereditary aTTR Amyloidosis Gene-Silencing Therapy

By

The FDA has accepted Alnylam's New Drug Application for patisiran, and investigational drug for treating hereditary aTTR amyloidosis, for priority review.

Apomorphine Film Effectively Treats Off State in Parkinson Disease

Apomorphine Film Effectively Treats Off State in Parkinson Disease

By

Apomorphine sublingual film showed superior efficacy for on-demand treatment of OFF episodes in patients with Parkinson's.

Interferon β-1a Delays 6-Month Confirmed Disability Progression in RRMS

Interferon β-1a Delays 6-Month Confirmed Disability Progression in RRMS

By

The post-hoc analysis compared 6-month confirmed disability progression using patient data from PRISMS-2.

Safety, Efficacy of Fingolimod vs IFN- β-1a in Adolescents With RRMS

Safety, Efficacy of Fingolimod vs IFN- β-1a in Adolescents With RRMS

By

The randomized, double-blind PARADIGM study compared the safety and efficacy of fingolimod and interferon β-1a in teens with relapsing-remitting MS.

More Articles by Da Hee Han

Sign Up for Free e-newsletters

CME Focus